Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score

Abstract Although Ki67 labeling index is a potential predictive marker for chemotherapy benefit, its clinical utility has been limited by the lack of a standard scoring method resulting in poor interobserver reproducibility. Especially, there is no consensus on the use of average versus hotspot scor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Soonmyung Paik, Youngmee Kwon, Moo Hyun Lee, Ji Ye Kim, Da Kyung Lee, Won Jeong Cho, Eun Young Lee, Eun Sook Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/1da6a665e76f4556ac906f59f8900391
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1da6a665e76f4556ac906f59f8900391
record_format dspace
spelling oai:doaj.org-article:1da6a665e76f4556ac906f59f89003912021-12-02T13:30:14ZSystematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score10.1038/s41523-021-00221-z2374-4677https://doaj.org/article/1da6a665e76f4556ac906f59f89003912021-02-01T00:00:00Zhttps://doi.org/10.1038/s41523-021-00221-zhttps://doaj.org/toc/2374-4677Abstract Although Ki67 labeling index is a potential predictive marker for chemotherapy benefit, its clinical utility has been limited by the lack of a standard scoring method resulting in poor interobserver reproducibility. Especially, there is no consensus on the use of average versus hotspot score for reporting. In order to determine the best method for Ki67 scoring and validate manual scoring method proposed by the International Ki67 Working Group (IKWG), we systematically compared average versus hotspot score in 240 cases with a public domain image analysis program QuPath. We used OncotypeDx Recurrence Score (RS) as a benchmark to compare the potential clinical utility of each scoring methods. Both average and hotspot scores showed statistically significant but only modest correlation with OncotypeDx RS. Only hotspot score could meaningfully distinguish RS low-risk versus high-risk patients. However, hotspot score was less reproducible limiting its clinical utility. In summary, our data demonstrate that utility of the Ki67 labeling index is influenced by the choice of scoring method.Soonmyung PaikYoungmee KwonMoo Hyun LeeJi Ye KimDa Kyung LeeWon Jeong ChoEun Young LeeEun Sook LeeNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Soonmyung Paik
Youngmee Kwon
Moo Hyun Lee
Ji Ye Kim
Da Kyung Lee
Won Jeong Cho
Eun Young Lee
Eun Sook Lee
Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
description Abstract Although Ki67 labeling index is a potential predictive marker for chemotherapy benefit, its clinical utility has been limited by the lack of a standard scoring method resulting in poor interobserver reproducibility. Especially, there is no consensus on the use of average versus hotspot score for reporting. In order to determine the best method for Ki67 scoring and validate manual scoring method proposed by the International Ki67 Working Group (IKWG), we systematically compared average versus hotspot score in 240 cases with a public domain image analysis program QuPath. We used OncotypeDx Recurrence Score (RS) as a benchmark to compare the potential clinical utility of each scoring methods. Both average and hotspot scores showed statistically significant but only modest correlation with OncotypeDx RS. Only hotspot score could meaningfully distinguish RS low-risk versus high-risk patients. However, hotspot score was less reproducible limiting its clinical utility. In summary, our data demonstrate that utility of the Ki67 labeling index is influenced by the choice of scoring method.
format article
author Soonmyung Paik
Youngmee Kwon
Moo Hyun Lee
Ji Ye Kim
Da Kyung Lee
Won Jeong Cho
Eun Young Lee
Eun Sook Lee
author_facet Soonmyung Paik
Youngmee Kwon
Moo Hyun Lee
Ji Ye Kim
Da Kyung Lee
Won Jeong Cho
Eun Young Lee
Eun Sook Lee
author_sort Soonmyung Paik
title Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
title_short Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
title_full Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
title_fullStr Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
title_full_unstemmed Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
title_sort systematic evaluation of scoring methods for ki67 as a surrogate for 21-gene recurrence score
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1da6a665e76f4556ac906f59f8900391
work_keys_str_mv AT soonmyungpaik systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
AT youngmeekwon systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
AT moohyunlee systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
AT jiyekim systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
AT dakyunglee systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
AT wonjeongcho systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
AT eunyounglee systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
AT eunsooklee systematicevaluationofscoringmethodsforki67asasurrogatefor21generecurrencescore
_version_ 1718392901664243712